Hostname: page-component-cb9f654ff-9knnw Total loading time: 0 Render date: 2025-08-01T21:13:07.586Z Has data issue: false hasContentIssue false
  • English
  • Français

Implementation of a Practical Antibiotic Policy in the Czech Republic

Published online by Cambridge University Press:  02 January 2015

Milan Kolár  and
Tomás Látal
Milan Kolár*
Affiliation:
Antibiotic Center, Faculty Hospital, Olomouc, Czech Republic
Tomás Látal
Affiliation:
Antibiotic Center, Faculty Hospital, Olomouc, Czech Republic
*
Medical Faculty and Faculty Hospital, Street Hnevotínská 3, Olomouc 775 15, Czech Republic
Get access Rights & Permissions [Opens in a new window]

Abstract

We describe the antibiotic control policy at the Faculty Hospital in Olomouc, Czech Republic. Practical examples of successful implementation of the policy are provided.

Information

Type
The International Perspective
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 6 , June 1999 , pp. 440 - 443
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fifth informational supplement. NCCLS document M100-S5 (M7-A3) 1994;14:1–12.Google Scholar
2. Urbášková, P, Hausnerová, S, et al. Methods in Microbiology. Assays for Antimicrobial Therapy [in Czech]. Prague, Czech Republic: Avicenum; 1985.Google Scholar
3. Krieg, NR, Holt, JG, et al. Bergey's Manual of Systematic Bacteriology, I. Baltimore, MD: Williams & Wilkins Co; 1984.Google Scholar
4. Paučková, V, et al. Methods of Microbiology. Laboratory Diagnostics of Non-fermenting Gram-Negative Rods [in Czech]. Prague, Czech Republic: Avicenum; 1989.Google Scholar
5. Jarlier, V, Nicolas, MH, Fournier, G, Philippon, A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867–878.Google Scholar
6. Kolár, M, Látal, T. Antibiotic resistance profile in Klebsiella pneumoniae strains with production of extended spectrum β-lactamases. Klin Mikrobiol Inf Lék 1997;3:110–114.Google Scholar
7. WHO Collaboration Centre for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) index (including defined daily doses [DDDs] for plain substances. Oslo, Norway: WHO Collaboration Centre for Drug Statistics Methodology; 1997.Google Scholar
8. Cormican, MG, Marshall, SA, Jones, RN. Detection of extended-spectrum β-lactamases (ESBL)-producing strains by the Etest ESBL screen. J Clin Microbiol 1996;34:1880–1884.CrossRefGoogle ScholarPubMed
9. Garau, J. β-lactamases: current situation and clinical importance. Intens Care Med 1994;20:5–9.CrossRefGoogle ScholarPubMed
10. Brun-Buisson, C, Legrand, P, Philippon, A, Montravers, F, Ansquer, M, Duval, J. Transferable enzymatic resistance to third generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae . Lancet 1987;11:302–306.Google Scholar
11. Knothe, H, Shah, P, Krcméry, V, Antal, M, Mitsuhashi, S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens . Infection 1983;11:315–317.CrossRefGoogle ScholarPubMed
12. Philippon, A, Labia, R, Jacoby, GA. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989;33:1131–1136.Google Scholar
13. Sanders, CC, Sanders, WE Jr. β-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992;15:824–839.CrossRefGoogle ScholarPubMed
14. Sirot, D, Sirot, J, Labia, R, Morand, A, Courvalin, P, Darfeuille-Michaud, A, et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 1987;20:323–334.Google Scholar
15. Thabaut, A, Acar, J, Allouch, P, Arlet, G, Berardi-Grassias, L, Bergogne-Berezin, E, et al. Fréquence et distribution des betalactamases chez 1792 souches Klebsiella pneumoniae isolées en France entre 1985 at 1988. Pathol Biol (Paris) 1990;38:459–463.Google ScholarPubMed
16. Livermore, DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557–584.Google Scholar
17. Medeiros, AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997;24:S19–S45.CrossRefGoogle ScholarPubMed
18. Richmond, MH, Sykes, RB. The β-lactamases of gramnegative bacteria and their possible physiological role. Adv Microb Physiol 1973;9:31–88.CrossRefGoogle ScholarPubMed
19. Ballow, CH, Schentag, JJ. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992;15:37S–42S.Google Scholar
20. Kolár, M, Látal, T. Implementation of the antibiotic policy in the Olomouc region—practical experience of the Center for Antibiotics at FH (Faculty Hospital) in Olomouc [in Czech]. Klin Mikrobiol Inf Lék 1996;7:162–165.Google Scholar
21. Jones, RN. The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on antibiotic resistance. Diagn Microbiol Infect Dis 1996;25:153–161.CrossRefGoogle ScholarPubMed